Inflammatory Th17 produce IFNγ and IL-17 and exert anti-tumor effects while regulatory Th17 secrete IL-10 and IL-17 and transform ATP into the immunosuppressive molecule adenosine thus sustaining tumor development (67). The gene discussed is IL17A; the disease is neoplasm.